- Presentations
- 3
- Markets
- 1
QuilliChew ER is a brand of Methylphenidate marketed by NextWave Pharmaceuticals, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Methylphenidate
- Brand owner
- NextWave Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 20 mg extended-release chewable tablet, 30 mg extended-release chewable tablet, 40 mg extended-release chewable tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| QuilliChew ER 20 mg extended-release chewable tabletOral | NextWave Pharmaceuticals | US FDA | Available on request |
| QuilliChew ER 30 mg extended-release chewable tabletOral | NextWave Pharmaceuticals | US FDA | Available on request |
| QuilliChew ER 40 mg extended-release chewable tabletOral | NextWave Pharmaceuticals | US FDA | Available on request |
Equivalent brands
Other brands of Methylphenidate.
RelexxiiVertical PharmaceuticalsMetadate CDLannettmethylphenidate hydrochloride CDLannettJORNAY PM Extended-ReleaseIronshore PharmaceuticalsMethylphenidate Hydrochloride (LA)Dr. Reddy's LaboratoriesConcertaJanssen PharmaceuticalsDaytranaNoven TherapeuticsCotempla XR-ODTNeos Therapeutics BrandsRitalinSandozMethylinShionogiQuillivant XRNextWave Pharmaceuticals
Brand names and trademarks belong to their owners and are used only to identify products.
Request QuilliChew ER
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.